Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells

Oncology Reports

Volumn 15, Issue 2, 2006, Pages 501-505

  Wu, Mingfu ^a   Xu, Gang ^a   Xi, Ling ^a   Wei, Junchen ^a   Song, Anping ^a   Han, Zhiqiang ^a   Zhou, Jianfeng ^a   Wang, Shixuan ^a   Zhu, Tao ^a   Zhang, Arli ^a   Lu, Yunping ^a   Ma, Ding ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Invasion and metastasis; MT1 MMP; Ovarian tumor

Indexed keywords

MATRIX METALLOPROTEINASE;

ARTICLE; CANCER INVASION; CELL PROLIFERATION; DOWN REGULATION; ENZYMOLOGY; FEMALE; GENETIC TRANSFECTION; HUMAN; METABOLISM; OVARY TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HUMANS; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 33744484332     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.2.501     Document Type: Article

References (40)

1. Naora H and Montell DJ: Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 5: 355-366, 2005.
2. Bogenrieder T and Herlyn M: Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22: 6524-6536, 2003.
3. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2003.
4. Seiki M: Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 194: 1-11, 2003.
5. Hiroshi S, Takahisa T and Hisashi M: Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis. Cancer Sci 96: 212-217, 2005.
6. Nomura H, Fujimoto N, Seiki M, Mai M and Okada Y: Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer 69: 9-16, 1996.
7. Nomura H, Sato H, Seiki M, Mai M and Okada Y: Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55: 3263-3266, 1995.
8. Ohtani H, Motohashi H, Sato H, Seiki M and Nagura H: Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy. Int J Cancer 68: 565-570, 1996.
9. Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M and Okada Y: Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 57: 2055-2060, 1997.
10. Jones JL, Glynn P and Walker RA: Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol 189: 161-168, 1999.
11. McCawley LJ and Matrisian LM: Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 13: 534-540, 2001.
12. Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839, 2003.
13. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65, 1994.
14. Brenda LP, Jouko L and Constance EB: Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2a in von Hippel-Lindau renal cell carcinoma. Oncogene 24: 1043-1052, 2005.
15. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA and Goldberg GI: Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270: 5331-5338, 1995.
16. Lehti K, Lohi J, Valtanen H and Keski-Oja J: Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J 334: 345-353, 1998.
17. Hotary K, Allen E, Punturieri A, Yana I and Weiss SJ: Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2 and 3. J Cell Biol 149: 1309-1323, 2000.
18. Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I and Seiki M: CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J 21: 3949-3959, 2002.
19. Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, Bahou WF, Docherty A and Cao J: Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1 matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273: 1216-1222, 1998.
20. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, d'Ortho MP and Murphy G: The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A: a kinetic study. J Biol Chem 273: 871-880, 1998.
21. Pei D and Weiss SJ: Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 271: 9135-9140, 1996.
22. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M and Okada Y: Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272: 2446-2451, 1997.
23. Vihinen P and Kahari VM: Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99: 157-166, 2002.
24. Yana I and Seiki M: MT-MMPs play pivotal roles in cancer dissemination. Clin Exp Metastasis 19: 209-215, 2002.
25. Kitagawa Y, Kunimi K, Uchibayashi T, Sato H and Namiki M: Expression of messenger RNAs for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinomas. J Urol 162: 905-909, 1999.
26. Iida J, Wilhelmson KL, Price MA, Wilson CM, Pei D, Furcht LT and McCarthy JB: Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth. J Invest Dermatol 122: 167-176, 2004.
27. Li J, Chen G, Ma D, et al: Reversion of ovarian carcinoma metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in orthotopic implantation model. Zhonghua Yi Xue Za Zhi 83: 1671-1675, 2003.
28. Rozanov DV, Savinov AY, Golubkov VS, et al: Cellular membrane type-1 matrix metalloproteinase (MT1-MMP) cleaves C3b, an essential component of the complement system. J Biol Chem 279: 46551-46557, 2004.
29. Heussen C and Dowdle EB: Electrophoretic analysis of plasminogen activation in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102: 196-202, 1980.
30. Graves LE, Ariztia EV, Navari JR, et al: Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 64: 7045-7049, 2004.
31. Ueda J, Kajita M, Suenaga N, et al: Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors. Oncogene 22: 8716-8722, 2003.
32. Yokota J: Tumor progression and metastasis. Carcinogenesis 21: 497-503, 2000.
33. Shawn ME, David AF, Alicia SK, Lisa MB and Sharon Stack M II: Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through b1 integrin1. Cancer Res 9: 1635-1641, 1999.
34. Davidson B, Goldberg I, Walter HG, Kopolovic J, Ben-Baruch G and Jahn M: High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma. Clin Exp Metastasis 17: 799-808, 1999.
35. Sounni NE, Devy L, Hajitou A, et al: MT1-MMP expression promotes tumor growth and angiogenesis through an upregulation of vascular endothelial growth factor expression. FASEB J 16: 555-564, 2002.
36. Hotary KB, Allen ED, Brooks PC, et al: Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 14: 33-45, 2003.
37. Stein CA and Cheng YV: Antisense oligonucleotides as therapeutic agents: is the bullet really magical. Science 261: 1004-1012, 1993.
38. Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW, Wang J, Cao Y and Tryggvason K: Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci USA 97: 4052-4057, 2000.
39. Zucker S, Cao J and Chen WT: Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 19: 6642-6650, 2000.
40. Dong Z, Kumar R, Yang X and Fidler IJ: Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88: 801-810, 1997.